CG Oncology (CGON) net assets (shareholders' equity)

Net assets · fiscal 2025
$752.60M

CG Oncology (CGON) had net assets of $752.60M at the end of fiscal 2025 (December 31, 2025). That is 2.6% higher than the $733.38M of fiscal 2024. Figures as of 19 Nov 2026, 00:22 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$752.60M
Change on fiscal 2024
+2.6%
Highest on record
$752.60Mfiscal 2025
Lowest on record
$125.18Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

CG Oncology net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $752.60M in fiscal 2025 and the lowest $125.18M in fiscal 2022.

History · 4 fiscal years

Net assets by fiscal year

CG Oncology net assets (shareholders' equity), year by year

CG Oncology (CGON) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$752.60M 2.6% up
2024$733.38M 296.9% up
2023$184.79M 47.6% up
2022$125.18M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of CG Oncology and comparable companies
CompanyNet assetsFiscal year
Oruka Therapeutics ORKA$471.93M2025
Arrowhead Pharmaceuticals ARWR$50.31M2026
MSA Safety MSA$1.37B2025
CG Oncology CGON$752.60M2025
Kodiak Sciences KOD$157.38M2025
Lantheus Holdings LNTH$1.09B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CGON

CG Oncology, figure by figure

CG Oncology (CGON) overview: price, valuation and scorecardAll health care companies by market value

CG Oncology net assets (shareholders' equity): questions and answers

What are CG Oncology's net assets?

CG Oncology (CGON) had net assets of $752.60M at the end of fiscal 2025 (December 31, 2025). That is 2.6% higher than the $733.38M of fiscal 2024.

What are the highest and lowest net assets figures on record for CG Oncology?

Across the 4 fiscal years on record (2022–2025), the highest was $752.60M in fiscal 2025 and the lowest $125.18M in fiscal 2022.

How is CG Oncology's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For CG Oncology it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CG Oncology (CGON) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/CGON/net-assets

Underlying data: Yahoo Finance.